Inventor · disambiguated record
Peter Carmeliet
Also filed as: CARMELIET PETER
21 granted patents·29 pending applications·138 citations·filing 2001–2016
94Inventor score
Files withVLAAMS INTERUNIV INST BIOTECH12CARMELIET PETER10LUDWIG INST CANCER RES3VIB VZW3D COLLEN RES FOUNDATION VZW2
Top patents by PatentIndex Score
50 records- 0187US7875704B2Anti-PLGF antibodyVLAAMS INTERUNIV INST BIOTECH·Filed 2006·Granted Jan 25, 2011·8 cites·17 claims
- 0285US8003096B2Means and methods for the recruitment and identification of stem cellsVLAAMS INTERUNIV INST BIOTECH·Filed 2006·Granted Aug 23, 2011·10 cites·11 claims
- 0384US7858593B2Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degenerationVIB VZW·Filed 2008·Granted Dec 28, 2010·13 cites·6 claims
- 0483US7357929B2Placental growth factor as a target for the treatment of osteoporosisD COLLEN RES FOUNDATION VZW·Filed 2003·Granted Apr 15, 2008·27 cites·1 claims
- 0583US7105168B1Method of improving ischemic muscle function by administering placental growth factorD COLLEN RES FOUNDATION VZW·Filed 2003·Granted Sep 12, 2006·14 cites·6 claims
- 0681US7482004B2Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2002·Granted Jan 27, 2009·13 cites·9 claims
- 0780US7867490B2Treatment of liver cirrhosis and its complicationsVIB VZW·Filed 2006·Granted Jan 11, 2011·7 cites·7 claims
- 0880US7307060B2Hypoxia inducible factor 2α for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertensionVLAAMS INTERUNIV INST BIOTECH·Filed 2005·Granted Dec 11, 2007·7 cites·5 claims
- 0979US7592314B2Use of VEGF and homologues to treat neuron disordersVIAAMS INTERUNIVERSITAIR INST·Filed 2007·Granted Sep 22, 2009·5 cites·4 claims
- 1078US6930089B2Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or strokeFLANDERS INTERUNIVERSITY INST·Filed 2001·Granted Aug 16, 2005·9 cites·13 claims
- 1177US7226908B2Use of VEGF and homologues to treat neuron disordersCOLLEN RES FOUNDATION VZW·Filed 2001·Granted Jun 5, 2007·14 cites·16 claims
- 1276US7687463B2Treatment of amyotrophic lateral sclerosisVLAAMS INTERUNIV INST BIOTECH·Filed 2005·Granted Mar 30, 2010·2 cites·7 claims
- 1373US8758748B2Anti-angiogenic therapySTASSEN JEAN-MARIE·Filed 2010·Granted Jun 24, 2014·3 cites·6 claims
- 1472US7709450B2Stimulation of vascularization with VEGF-B-186LUDWIG INST CANCER RES·Filed 2002·Granted May 4, 2010·6 cites·11 claims
- 1569US7888322B2Use of VEGF and homologues to treat neuron disordersVLAAMS INTERUNIV INST BIOTECH·Filed 2008·Granted Feb 15, 2011·0 cites·5 claims
- 1665US2009238826A1Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2009·Application pending·0 cites
- 1764US2009074765A1Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2008·Application pending·0 cites
- 1864US2009162354A1Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakageVLAAMS INTERUNIV INST BIOTECH·Filed 2008·Application pending·0 cites
- 1963US7727971B2Use of placental growth factor for treating ischemic muscle diseaseLIFE SCIENCES RES PARTNERS VZW·Filed 2006·Granted Jun 1, 2010·0 cites·12 claims
- 2060US9085617B2Anti-angiogenic therapyVLAAMS INTERUNIV INST BIOTECH·Filed 2014·Granted Jul 21, 2015·0 cites·22 claims
- 2158US2004053837A1Composition and method for modulating vasculogenesis or angiogenesisLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
- 2255US2013177565A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2013·Application pending·0 cites
- 2355US2013183310A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2013·Application pending·0 cites
- 2455US2013177564A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2013·Application pending·0 cites
- 2554US2007172423A1Composition and method for modulating vasculogenesis for angiogenesisLI XURI·Filed 2006·Application pending·0 cites
- 2654US2009234150A1Use of ppar-alpha agonists to treat skeletal muscle wasting disordersCARMELIET PETER·Filed 2007·Application pending·0 cites
- 2754US2012263710A1Administering anti-placental growth factor antibodiesCARMELIET PETER·Filed 2012·Application pending·0 cites
- 2853US2010178297A1Means and methods for the recruitment and identification of stem cellsVLAAMS INTERUNIV INST BIOTECH·Filed 2009·Application pending·0 cites
- 2951US2005119198A1Novel target to inhibit angiogenesisFiled 2003·Application pending·0 cites
- 3051US2005186204A1Use of antibodies against FLT-1 for the treatment of osteoporosisFiled 2004·Application pending·0 cites
- 3150US2003211994A1Composition and method for modulating vasculogenesis or angiogenesisLUDWIG INST CANCER RES·Filed 2002·Application pending·0 cites
- 3250US2011288020A1Use of VEGF and homologues to treat neuron disordersCARMELIET PETER·Filed 2010·Application pending·0 cites
- 3350US2007107072A1Transgenic amphibian models for lymphatic vessel developmentCARMELIET PETER·Filed 2004·Application pending·0 cites
- 3450US2006183671A1Treatment of anemiaANGELILLO-SCHERRER ANNE·Filed 2004·Application pending·0 cites
- 3550US2005043227A1Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertensionFiled 2002·Application pending·0 cites
- 3650US2015004136A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3749US10106601B2Inhibition of PLGF to treat philadelphia chromosome positive leukemiaCARMELIET PETER·Filed 2009·Granted Oct 23, 2018·0 cites·11 claims
- 3848US7863246B2Treatment of amyotrophic lateral sclerosisVLAAMS INTERUNIV INST BIOTECH·Filed 2010·Granted Jan 4, 2011·0 cites·5 claims
- 3947US9234025B2Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptorCARMELIET PETER·Filed 2010·Granted Jan 12, 2016·0 cites·11 claims
- 4046US2016193192A1Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptorSANOFI SA·Filed 2015·Application pending·0 cites
- 4145US2004248796A1VEGF-B and PDGF modulation of stem cellsFiled 2004·Application pending·0 cites
- 4245US2016166532A1Carnitine palmitoyltransferase 1 inhibitors for inhibition of pathological angiogenesisVIB VZW·Filed 2014·Application pending·0 cites
- 4344US2017066822A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4443US2005163781A1Tissue adhesion formation controlFiled 2003·Application pending·0 cites
- 4539US2013078224A1Induction/monitoring of arteriogenesis using sdf1 and pdgfb or inhibition of phd2MAZZONE MASSIMILIANO·Filed 2011·Application pending·0 cites
- 4639US2003125233A1Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodellingFiled 2001·Application pending·0 cites
- 4736US8741862B2PHD2 inhibition for blood vessel normalization, and uses thereofCARMELIET PETER·Filed 2010·Granted Jun 3, 2014·0 cites·19 claims
- 4836US2004247597A1Method of treating atherosclerosis and other inflammatory diseasesFiled 2002·Application pending·0 cites
- 4935US2003144237A1Use of inhibition of a gas6 function or of a gas6 receptor for preventing and treating a cardiovascular diseaseFiled 2001·Application pending·0 cites
- 5032US2012195858A1Responsiveness to angiogenesis inhibitorsFOERNZLER DOROTHEE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Carmeliet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →